Vaccines and Hair Loss |
|
|
Clinical Trial: Alopecia Areata Registry
This study is currently recruiting patients.
|
Purpose
Alopecia areata is the loss of hair in oval patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
| Condition |
|---|
| Alopecia Areata Alopecia Totalis Alopecia Universalis Autoimmune Hair Loss Alopecia Partialis |
MedlinePlus related topics: Hair Diseases and Hair Loss
Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Retrospective/Prospective Study
Expected Total Enrollment: 2500
Study start: November 2001
Alopecia areata is a fairly common disease in which hair is lost either from part of the scalp, all of the scalp, or the entire body. It is thought to be an autoimmune disease and in some cases the disease is hereditary. The Alopecia Areata Registry will collect information and blood samples from clinically well-characterized patients with these three forms of alopecia areata: alopecia partialis (patchy loss of the scalp hair), alopecia totalis (total loss of all scalp hair), and alopecia universalis (complete loss of all hair everywhere on the body). This will be a collection of patients both in multi-generational families and in sib pairs with controls. Information from these patients will be used to search the human genome for disease-associated loci and/or genes. Researchers interested in doing pathophysiology or treatment studies of this disease will also be able to contact patients having the appropriate form of the disease for the studies in question.
Patients who have been diagnosed with alopecia areata by a dermatologist will be eligible for the registry. Patients will fill out an information form online (alopeciaareataregistry.org). Patients who have a family history or specific types of alopecia will be invited to participate in a more detailed questionnaire and physical exam and have blood samples drawn.
Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location and Contact Information
California
University of California, San Francisco, San Francisco, California, 94143, United States; Recruiting
Vera Price, MD, Sub-Investigator
Colorado
UCHSC of Colorado - Health Science Center at Fitzsimons, Aurora, Colorado, 80010-7163, United States; Recruiting
David Norris, MD, Principal Investigator
Minnesota
University of Minnesota, Minneapolis, Minnesota, 55455, United States; Recruiting
Maria Hordinsky, MD, Sub-Investigator
New York
Columbia University, New York, New York, 10032, United States; Recruiting
Angela Christiano, PhD, Sub-Investigator
Texas
M.D. Anderson Cancer Center, Houston, Texas, 77030, United States; Recruiting
Madeleine Duvic, MD, Principal Investigator
Madeleine Duvic, MD, Principal Investigator, M.D. Anderson Cancer Center
More Information
Web site for the Alopecia Areata Registry
Publications
Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003 Oct; 8(2): 219-21.
Record last reviewed: April 2005
Last Updated: April 7, 2005
Record first received: September 29, 2003
ClinicalTrials.gov Identifier: NCT00069589
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


